We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBGI icon
3376
Sinclair Inc
SBGI
$1.07B
$24K ﹤0.01%
851
+504
+145% +$14K
SNEX icon
3377
StoneX
SNEX
$8.09B
$24K ﹤0.01%
1,635
-1,165
-42% -$16.2K
STBA icon
3378
S&T Bancorp
STBA
$1.8B
$24K ﹤0.01%
828
+531
+179% +$16.7K
VRE
3379
DELISTED
Veris Residential
VRE
$24K ﹤0.01%
1,366
-2,840
-68% -$49.3K
ZNTL icon
3380
Zentalis Pharmaceuticals
ZNTL
$255M
$24K ﹤0.01%
518
-3,424
-87% -$185K
SPPI
3381
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$24K ﹤0.01%
18,949
-66,864
-78% -$61.6K
USX
3382
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$24K ﹤0.01%
6,314
+3,557
+129% +$15.9K
ALR
3383
DELISTED
AlerisLife Inc
ALR
$24K ﹤0.01%
11,081
+1,159
+12% +$3.11K
GCP
3384
DELISTED
GCP Applied Technologies Inc.
GCP
$24K ﹤0.01%
785
-1,127
-59% -$35.7K
AAXJ icon
3385
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.84B
$23K ﹤0.01%
304
-2,392
-89% -$189K
BNR
3386
Burning Rock Biotech
BNR
$93.1M
$23K ﹤0.01%
245
+222
+965% +$19.3K
BSRR icon
3387
Sierra Bancorp
BSRR
$532M
$23K ﹤0.01%
904
-87
-9% -$2.32K
CENN icon
3388
Cenntro
CENN
$8.63M
$23K ﹤0.01%
17
– –
CWB icon
3389
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.76B
$23K ﹤0.01%
+303
New +$23.2K
EGHT icon
3390
8x8 Inc
EGHT
$300M
$23K ﹤0.01%
1,777
-1,294
-42% -$17.9K
FCPT icon
3391
Four Corners Property Trust
FCPT
$2.77B
$23K ﹤0.01%
849
-24,751
-97% -$666K
HL icon
3392
Hecla Mining
HL
$12.3B
$23K ﹤0.01%
3,542
-63,773
-95% -$369K
MCHB
3393
Mechanics Bancorp
MCHB
$3.78B
$23K ﹤0.01%
486
+308
+173% +$15.7K
MAYS icon
3394
J.W. Mays
MAYS
$83.7M
$23K ﹤0.01%
606
+309
+104% +$12.3K
MC icon
3395
Moelis & Co
MC
$5.07B
$23K ﹤0.01%
497
-155
-24% -$8.06K
MODD icon
3396
Modular Medical
MODD
$13.5M
$23K ﹤0.01%
+176
New +$20.6K
IMDX
3397
Insight Molecular Diagnostics
IMDX
$141M
$23K ﹤0.01%
773
+83
+12% +$2.65K
PCVX icon
3398
Vaxcyte
PCVX
$8.64B
$23K ﹤0.01%
979
-648
-40% -$14.2K
PMVP icon
3399
PMV Pharmaceuticals
PMVP
$67.2M
$23K ﹤0.01%
1,085
-8,595
-89% -$152K
PRGS icon
3400
Progress Software
PRGS
$1.79B
$23K ﹤0.01%
477
-2,437
-84% -$110K
134 135
136
137 138

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.